Increased mortality rate and suicide in Swedish former elite male athletes in power sports

Physical training has been shown to reduce mortality in normal subjects, and athletes have a healthier lifestyle after their active career as compared with normal subjects. Since the 1950s, the use of anabolic androgenic steroids (AAS) has been frequent, especially in power sports. The aim of the present study was to investigate mortality, including causes of death, in former Swedish male elite athletes, active 1960–1979, in wrestling, powerlifting, Olympic lifting, and the throwing events in track and field when the suspicion of former AAS use was high. Results indicate that, during the age period of 20–50 years, there was an excess mortality of around 45%. However, when analyzing the total study period, the mortality was not increased. Mortality from suicide was increased 2–4 times among the former athletes during the period of 30–50 years of age compared with the general population of men. Mortality rate from malignancy was lower among the athletes. As the use of AAS was marked between 1960 and 1979 and was not doping‐listed until 1975, it seems probable that the effect of AAS use might play a part in the observed increased mortality and suicide rate. The otherwise healthy lifestyle among the athletes might explain the low malignancy rates.

[1]  T. Rosén,et al.  A retrospective 30-year follow-up study of former Swedish-elite male athletes in power sports with a past anabolic androgenic steroids use: a focus on mental health , 2013, British Journal of Sports Medicine.

[2]  Hui-Xin Wang,et al.  Lifestyle, social factors, and survival after age 75: population based study , 2012, BMJ : British Medical Journal.

[3]  D. Malcolm,et al.  Suicide, sport and medicine , 2012, British Journal of Sports Medicine.

[4]  D. Corella,et al.  Increased Average Longevity among the “Tour de France” Cyclists , 2011, International journal of sports medicine.

[5]  M. Teramoto,et al.  Mortality and longevity of elite athletes. , 2010, Journal of science and medicine in sport.

[6]  L. Engebretsen,et al.  Cancer risk in Norwegian world class athletes , 2010, Cancer Causes & Control.

[7]  P. Verger,et al.  Public awareness campaigns about depression and suicide: a review. , 2009, Psychiatric services.

[8]  A. Wolk,et al.  Total mortality after changes in leisure time physical activity in 50 year old men: 35 year follow-up of population based cohort , 2009, BMJ : British Medical Journal.

[9]  N. Evans,et al.  Anabolic androgenic steroids: a survey of 500 users. , 2006, Medicine & Science in Sports & Exercise.

[10]  B. Saltin,et al.  Evidence for prescribing exercise as therapy in chronic disease , 2006, Scandinavian journal of medicine & science in sports.

[11]  A. L. Baum Suicide in athletes: a review and commentary. , 2005, Clinics in sports medicine.

[12]  L. Demers,et al.  Measures of aggression and mood changes in male weightlifters with and without androgenic anabolic steroid use. , 2003, Journal of forensic sciences.

[13]  Thomas J. H. Chen,et al.  The Reward Deficiency Syndrome: A Biogenetic Model for the Diagnosis and Treatment of Impulsive, Addictive and Compulsive Behaviors , 2000, Journal of psychoactive drugs.

[14]  U. Kujala,et al.  Increased premature mortality of competitive powerlifters suspected to have used anabolic agents. , 2000, International journal of sports medicine.

[15]  P. Palatini,et al.  Cardiovascular Effects of Anabolic Steroids in Weight‐Trained Subjects , 1996, Journal of clinical pharmacology.

[16]  C. J. Cooper,et al.  A high prevalence of abnormal personality traits in chronic users of anabolic-androgenic steroids. , 1996, British journal of sports medicine.

[17]  S. Hansen,et al.  Personality Profile of Men Using Anabolic Androgenic Steroids , 1996, Hormones and Behavior.

[18]  J. Porcerelli,et al.  Narcissism and empathy in steroid users. , 1995, The American journal of psychiatry.

[19]  R S Paffenbarger,et al.  Exercise intensity and longevity in men. The Harvard Alumni Health Study. , 1995, JAMA.

[20]  M. Ward,et al.  5. Anabolic Steroids — The Drugs That Give and Take Away Manhood. A Case with an Unusual Physical Sign , 1994, Medicine, science, and the law.

[21]  O. Wolkowitz,et al.  Neuropsychiatric effects of anabolic steroids in male normal volunteers. , 1993, JAMA.

[22]  J. Kaprio,et al.  Increased life expectancy of world class male athletes. , 1993, Medicine and science in sports and exercise.

[23]  W. Yates,et al.  Aggression and hostility in anabolic steroid users , 1992, Biological Psychiatry.

[24]  M. O’Connor,et al.  Cognitive impairment after ECT in patients with Parkinson's disease and psychiatric illness. , 1992, The American journal of psychiatry.

[25]  B. Bower Pumped up and Strung Out , 1991 .

[26]  M. B. Snyder,et al.  Anabolic-androgenic steroid use by athletes. , 1989, The New England journal of medicine.

[27]  T. Beresford,et al.  Anabolic androgenic steroids and suicide. , 1989, The American journal of psychiatry.

[28]  K. Friedl,et al.  Self-Reported Use of Anabolic-Androgenic Steroids by Elite Power Lifters. , 1988, The Physician and sportsmedicine.

[29]  Juha Pekkanen,et al.  REDUCTION OF PREMATURE MORTALITY BY HIGH PHYSICAL ACTIVITY: A 20-YEAR FOLLOW-UP OF MIDDLE-AGED FINNISH MEN , 1987, The Lancet.

[30]  R. Paffenbarger,et al.  Physical activity, all-cause mortality, and longevity of college alumni. , 1986, The New England journal of medicine.

[31]  A. Ljungqvist The use of anabolic steroids in top Swedish athletes. , 1975, British journal of sports medicine.

[32]  J. Pacheco,et al.  Suicide , 1968, Royal Institute of Philosophy Lectures.

[33]  P. Martelletti,et al.  The role of physical activity in the prevention and treatment of chronic diseases. , 2010, La Clinica terapeutica.

[34]  Harm Kuipers,et al.  Effects of Androgenic-Anabolic Steroids in Athletes , 2004, Sports medicine.

[35]  P. Fudala,et al.  An evaluation of anabolic-androgenic steroid abusers over a period of 1 year: seven case studies. , 2003, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

[36]  F. Hartgens,et al.  Prospective echocardiographic assessment of androgenic-anabolic steroids effects on cardiac structure and function in strength athletes. , 2003, International journal of sports medicine.

[37]  T. Seppälä,et al.  Steroid Use and Long-Term Health Risks in Former Athletes , 2002, Sports medicine.

[38]  I. Thiblin,et al.  Cause and manner of death among users of anabolic androgenic steroids. , 2000, Journal of forensic sciences.

[39]  J. T. Dalby,et al.  Brief anabolic steroid use and sustained behavioral reaction. , 1992, The American journal of psychiatry.

[40]  B. Berendonk Die Entartung des Sports zum Wettkampf der Lügen , 1991 .

[41]  B. Berendonk Doping Dokumente : von der Forschung zum Betrug , 1991 .

[42]  J. Cohn,et al.  Double-blind, multicenter comparison of sertraline and amitriptyline in elderly depressed patients. , 1990, The Journal of clinical psychiatry.

[43]  D. Katz,et al.  Homicide and near-homicide by anabolic steroid users. , 1990, The Journal of clinical psychiatry.

[44]  A. de Merode Doping tests at the Olympic Games in 1976. , 1979, The Journal of sports medicine and physical fitness.

[45]  M. Chafetz Public awareness. , 1975, The Investor-owned hospital review.